Delivery Order SPE2DB22D3016-SPE2DB25FBGS6
Award Date 8/29/25
Potential Completion Date 9/22/25
Potential Value $22K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $43,664.64 delivery order to AmerisourceBergen Drug Corp for NOVOSEVEN RT 5 mg vials, with an ultimate completion date of August 22, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. NOVOSEVEN RT is a recombinant activated Factor VII used primarily for hemostasis support in military and veteran healthcare settings,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a competitively-procured delivery order valued at approximately $51K for NOVOSEVEN RT 5 mg vials. The contract, issued by the Defense Logistics Agency under its Defense Supply Chain operations, carries a firm fixed price structure and is scheduled for completion by September 12, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency has awarded a delivery order valued at $5,772.72 to AmerisourceBergen Drug Corp for the supply of Novoseven RT 2 mg vials. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply agreement extending through December 2026. The delivery order is scheduled for completion by August 15, 2025, with fulfillment...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $82,935.48 firm-fixed-price contract is for the supply of NovoSeven RT 5 mg vials, a pharmaceutical product. The contract has an ultimate completion date of August 5, 2024. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle...
- This federal contract award is for the delivery of NovoSeven RT 5 mg vials to the Defense Logistics Agency (DLA). The $80,051.84 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 14, 2025, with a completion date of April 4, 2025. This award is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of NOVOSEVEN RT 5 MG VIALS, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $43,664.64 and a period of performance through July 7, 2025. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,750.80 firm fixed-price delivery order is for the supply of 4,566,658,071 units of the medication NovoSeven RT 5 mg vials. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $42,900.96 Firm Fixed Price delivery order contract is for the supply of NovoSeven RT 5 mg vials, a specialty medication. The contract has an ultimate completion date of December 23, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,512.66 to AmerisourceBergen Drug Corp for 1,500 unit vials of Novoeight, a pharmaceutical product, with performance in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 18, 2025, and represents a child contract under a larger indefinite delivery vehicle. No set-aside designation was applied to this procurement. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,944.90 delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL vials (10 mL) on August 22, 2025, with an ultimate completion date of August 25, 2025. This contract was competitively awarded without any set-aside designation and is structured as a firm fixed price delivery order. The pharmaceutical product will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....